The association of Chlamydia pneumoniae infection and reactive airway disease in children.
OBJECTIVE
To determine the possible association of Chlamydia pneumoniae infection and reactive airway disease in children.


METHODS
Prospective observational study.


METHODS
Pediatric emergency department in Children's Medical Center of Brooklyn (NY), Kings County Hospital Center.


METHODS
One hundred eighteen children with acute episodes of wheezing and 41 age- and sex-matched healthy controls, aged 5 to 16 years.


METHODS
Children with cultures positive for C pneumoniae were treated with antibiotics.


RESULTS
Cultures for C pneumoniae and serum samples for antibody testing were obtained from subjects and healthy controls. We isolated C pneumoniae from 13 (11%) children with wheezing and from two (4.9%) controls. Seven (58.3%) of 12 children with positive cultures had no detectable antibody to C pneumoniae and only three (25%) children had serologic evidence of acute infection. Six children had positive cultures on multiple occasions, ranging from 1 to 5 months. The children with wheezing were treated with erythromycin or clarithromycin, a new macrolide antibiotic approved for use in adults; all eventually had a negative culture. Nine (75%) of these children demonstrated clinical and laboratory improvement of the reactive airway disease after the eradication of chlamydial infection.


CONCLUSIONS
Infection with C pneumoniae can trigger acute episodes of wheezing in children with asthma. Treatment of C pneumoniae infection may improve the course of reactive airway disease in these patients.
Department of Pediatrics, State University of New York Health Science Center, Brooklyn.
U
U
Emre
P M
PM
Roblin
M
M
Gelling
W
W
Dumornay
M
M
Rao
M R
MR
Hammerschlag
J
J
Schachter
D000293:Adolescent; D001249:Asthma / Q000209:etiology* / Q000382:microbiology; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D002690:Chlamydia Infections / Q000150:complications* / Q000382:microbiology; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies